Title

A Rare Case of Diffuse Alveolar Hemorrhage Secondary to Dabigatran Successfully Treated with Extracorporeal Membrane Oxygenation

Authors

C. Hutchinson, Thomas Jefferson UniversityFollow
F. M. West, Thomas Jefferson University
H. Hirose, Thomas Jefferson UniversityFollow

Files

Description

Introduction

Dabigatran, a direct thrombin inhibitor, is used for stroke risk reduction in non-valvular atrial fibrillation and for treatment and prevention of venous thromboembolism. Minor side effects include indigestion and stomach pain. Major life threatening bleeding occurs in up to 2% of patients and is largely attributed to gastrointestinal hemorrhage. Here, we describe a case of a dabigatran related diffuse alveolar hemorrhage (DAH) treated successfully with extracorporeal membrane oxygenation.

Publication Date

5-22-2018

Keywords

pulmonary hemorrhage, ECMO, ARDS

Disciplines

Cardiology | Critical Care | Medicine and Health Sciences | Pulmonology

Comments

Presented at the 2018 American Thoracic Society Conference

Recommended Citation

Hutchinson, C.; West, F. M.; and Hirose, H., "A Rare Case of Diffuse Alveolar Hemorrhage Secondary to Dabigatran Successfully Treated with Extracorporeal Membrane Oxygenation" (2018). Department of Medicine Posters. 13.
https://jdc.jefferson.edu/medposters/13